BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17565718)

  • 1. Akt2 is implicated in skeletal muscle differentiation and specifically binds Prohibitin2/REA.
    Héron-Milhavet L; Mamaeva D; Rochat A; Lamb NJ; Fernandez A
    J Cell Physiol; 2008 Jan; 214(1):158-65. PubMed ID: 17565718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation.
    Sun L; Liu L; Yang XJ; Wu Z
    J Cell Sci; 2004 Jun; 117(Pt 14):3021-9. PubMed ID: 15173318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding.
    Héron-Milhavet L; Franckhauser C; Rana V; Berthenet C; Fisher D; Hemmings BA; Fernandez A; Lamb NJ
    Mol Cell Biol; 2006 Nov; 26(22):8267-80. PubMed ID: 16982699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKR is a novel functional direct player that coordinates skeletal muscle differentiation via p38MAPK/AKT pathways.
    Alisi A; Spaziani A; Anticoli S; Ghidinelli M; Balsano C
    Cell Signal; 2008 Mar; 20(3):534-42. PubMed ID: 18164587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FHL3 binds MyoD and negatively regulates myotube formation.
    Cottle DL; McGrath MJ; Cowling BS; Coghill ID; Brown S; Mitchell CA
    J Cell Sci; 2007 Apr; 120(Pt 8):1423-35. PubMed ID: 17389685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta's delay skeletal muscle progenitor cell differentiation in an isoform-independent manner.
    Schabort EJ; van der Merwe M; Loos B; Moore FP; Niesler CU
    Exp Cell Res; 2009 Feb; 315(3):373-84. PubMed ID: 19038250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prader-Willi syndrome protein necdin interacts with the E1A-like inhibitor of differentiation EID-1 and promotes myoblast differentiation.
    Bush JR; Wevrick R
    Differentiation; 2008 Nov; 76(9):994-1005. PubMed ID: 18557765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRB3 modulates C2C12 differentiation by interfering with Akt activation.
    Kato S; Du K
    Biochem Biophys Res Commun; 2007 Feb; 353(4):933-8. PubMed ID: 17207467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of nPKC theta is permissive for myogenic differentiation.
    Miles K; Wagner M
    J Cell Biochem; 2000 Jul; 79(1):71-9. PubMed ID: 10906756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels.
    Falcone G; Ciuffini L; Gauzzi MC; Provenzano C; Strano S; Gallo R; Castellani L; Alemà S
    Oncogene; 2003 Nov; 22(51):8302-15. PubMed ID: 14614454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of the LAZ3 (BCL6) proto-oncogene accompanies murine skeletal myogenesis.
    Albagli-Curiel O; Dhordain P; Lantoine D; Auradé F; Quief S; Kerckaert JP; Montarras D; Pinset C
    Differentiation; 1998 Nov; 64(1):33-44. PubMed ID: 9921651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine kinase activity is required for myogenic differentiation of C2C12 myoblasts.
    Meacci E; Nuti F; Donati C; Cencetti F; Farnararo M; Bruni P
    J Cell Physiol; 2008 Jan; 214(1):210-20. PubMed ID: 17654519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-binding motif protein 24 regulates myogenin expression and promotes myogenic differentiation.
    Jin D; Hidaka K; Shirai M; Morisaki T
    Genes Cells; 2010 Nov; 15(11):1158-67. PubMed ID: 20977548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel zinc finger protein Zfp637 behaves as a repressive regulator in myogenic cellular differentiation.
    Li K; Zhang J; Ren JJ; Wang Q; Yang KY; Xiong ZJ; Mao YQ; Qi YY; Chen XW; Lan F; Wang XJ; Xiao HY; Lin P; Wei YQ
    J Cell Biochem; 2010 May; 110(2):352-62. PubMed ID: 20235149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerin expression at the early stages of myogenic differentiation.
    Lattanzi G; Ognibene A; Sabatelli P; Capanni C; Toniolo D; Columbaro M; Santi S; Riccio M; Merlini L; Maraldi NM; Squarzoni S
    Differentiation; 2000 Dec; 66(4-5):208-17. PubMed ID: 11269947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for PKCepsilon during C2C12 myogenic differentiation.
    Gaboardi GC; Ramazzotti G; Bavelloni A; Piazzi M; Fiume R; Billi AM; Matteucci A; Faenza I; Cocco L
    Cell Signal; 2010 Apr; 22(4):629-35. PubMed ID: 19954762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts.
    Sumitani S; Goya K; Testa JR; Kouhara H; Kasayama S
    Endocrinology; 2002 Mar; 143(3):820-8. PubMed ID: 11861503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK2 is required for efficient terminal differentiation of skeletal myoblasts.
    Li J; Johnson SE
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1425-33. PubMed ID: 16729973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of mouse c-ski accompanies terminal skeletal muscle differentiation in vivo and in vitro.
    Namciu S; Lyons GE; Micales BK; Heyman HC; Colmenares C; Stavnezer E
    Dev Dyn; 1995 Nov; 204(3):291-300. PubMed ID: 8573720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA-binding proteins Rbm38 and Rbm24 regulate myogenic differentiation via p21-dependent and -independent regulatory pathways.
    Miyamoto S; Hidaka K; Jin D; Morisaki T
    Genes Cells; 2009 Nov; 14(11):1241-52. PubMed ID: 19817877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.